While similar benefits have been reported in transgenic mutant SOD1 mouse models of ALS [16, 30, 56]this is the first study to demonstrate similar benefits of this approach for wild-type SOD1 pathology in vivo. Here, SOD1 is linked to amyotrophic lateral sclerosis.